Methylphenidate and the risk of acute central nervous system oxygen toxicity: a rodent model and observational data in human divers | Canada Hyperbarics Skip to main content
Study Diving Hyperb Med 2024

Methylphenidate and the risk of acute central nervous system oxygen toxicity: a rodent model and observational data in human divers

Gur I, Arieli Y, Matsliah Y — Diving Hyperb Med, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers examined whether methylphenidate (Ritalin, used for ADHD) increases the risk of central nervous system oxygen toxicity seizures, using both human observational data from 75 diving cases and a mouse experiment with escalating methylphenidate doses.

What They Found

In human data, methylphenidate was not associated with increased seizure risk (OR 0.72, 95% CI 0.16 to 3.32). In mice, higher methylphenidate doses extended the time before seizure onset significantly (877 seconds at baseline versus 1,500 seconds at the highest dose, p=0.014), suggesting a possible protective effect.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The human sample was small (75 cases) from a specific military diving population; mice were exposed to very high oxygen pressures not typical of clinical HBOT.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Decompression Sickness
Source Pubmed
PubMed ID 39288920
Year Published 2024
Journal Diving Hyperb Med
MeSH Terms Methylphenidate; Animals; Male; Central Nervous System Stimulants; Mice; Diving; Adult; Humans; Oxygen; Seizures; Female; Middle Aged; Hyperbaric Oxygenation; Young Adult; Time Factors

Cite This Study

Share

This study relates to Decompression Sickness. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Decompression Sickness

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology